Abstract
In the original article, there was an error. The IRB Number of our article, “IRB No: 202100961B0”, was typed mistakenly as “IRB No: 20210096B0”. A correction has been made to the last sentence of the Materials and Methods, Patients and the Ethics Statement”. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Author supplied keywords
Cite
CITATION STYLE
Kuo, Y. H., Lu, S. N., Chen, Y. Y., Kee, K. M., Yen, Y. H., Hung, C. H., … Wang, J. H. (2021, December 14). Corrigendum: Real-World Lenvatinib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis (Front. Oncol., (2021), 11, (737767), 10.3389/fonc.2021.737767). Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2021.823960
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.